Tuberculosis (TB) continues to be a major global health challenge, impacting over 10 million people annually. On October 20, leading researchers from around the world convened at the Nobel Forum to address critical gaps in prevention, care, and research related to this infectious disease. Despite notable advancements in treatment outcomes, tuberculosis remains the world’s deadliest infectious disease, claiming numerous lives each year.
The symposium, titled “Global Health and Tuberculosis,” was organized by the Karolinska Institutet’s tuberculosis research network. The event commenced with a keynote address by Professor Madhukar Pai from McGill University in Canada. He outlined the “know-do” gap in TB management, emphasizing the disparity between existing knowledge and practical applications. This gap contributes to ongoing issues in diagnosis, treatment, and prevention, highlighting the need for a more person-centered approach to TB care.
Professor Pai also stressed the importance of involving TB survivors in research efforts, noting that their perspectives are often overlooked in studies conducted in Western contexts. “Their voices and experiences are crucial for lasting progress,” he asserted.
Dr. Senia Rosales-Klintz from the European Centre for Disease Prevention and Control (ECDC) addressed the financial challenges posed by limited drug licenses within the European Union. These restrictions lead to exorbitant treatment costs for individual nations, disproportionately affecting migrants. As a result, many migrants experience disparities in access to care across Europe and, in some cases, may receive better treatment in countries where TB is endemic.
The discussion continued with Professor Giovanni B. Migliori from the World Health Organization (WHO) who presented findings on the long-term consequences of post-TB lung disease. He highlighted how physical rehabilitation can significantly enhance the quality of life for former patients long after treatment concludes.
The final speaker of the symposium, Associate Professor Lina Davies Forsman from Karolinska Institutet and Karolinska University Hospital, showcased ongoing research collaborations between Karolinska and institutions in Vietnam and China. These partnerships aim to bolster TB management and enhance patient outcomes in high-burden regions.
The event concluded with a poignant reminder encapsulated in the theme: “Nothing about us, without us.” This statement underscores the necessity for collaborative approaches to global TB control that incorporate insights from TB survivors and communities most affected by the disease. Their experiences are pivotal in shaping effective strategies for combating tuberculosis on a worldwide scale.
